PRF Technologies Announces FDA Clearance of IND Application for OcuRingâ„¢-K Phase II Clinical Trial
Milestone supports advancement of PRF’s drop-less ocular drug-delivery platform into next-stage U.S. clinical development for post-cataract pain and inflammation ...
TEL AVIV - PRF Technologies Ltd. (NASDAQ:PRFX) announced Thursday it has changed its corporate name from PainReform following shareholder approval at its Annual General Meeting on January 6. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results